Targeting Myeloid-Derived Suppressor Cells (MDSCs) and Tumour-Associated Macrophages (TAMs) with Mavrilimumab to restore anti-cancer immunity

  • Mussai, Francis (Principal Investigator)

Project Details

Short titleTargeting Myeloid-Derived Suppressor Cells (MDSCs) and Tumour-Associated Macrophages (TAMs) with Mavrilimumab to restore anti-cancer immunity
StatusFinished
Effective start/end date1/01/20 → 30/04/21

Funding

  • Kiniksa Pharmaceuticals